Search - tctmd.com

Displaying 701 - 720 of 1167

Sort: Relevancy | Date

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Daily News

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

L.A. McKeown

December 07, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Featured Fellow

Benjamin Z. Galper, MD, MPH

Yael L. Maxwell

November 15, 2015

News Daily News

美国TAVR登记处中有超过十分之一的患者接受过标签外治疗

Shelley Wood

November 12, 2015

News Daily News

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

Shelley Wood

November 12, 2015

News Daily News

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

Shelley Wood

November 11, 2015

News Industry News

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

November 10, 2015

News Daily News

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

L.A. McKeown

November 01, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Advertisement

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Benjamin Z. Galper, MD, MPH

美国TAVR登记处中有超过十分之一的患者接受过标签外治疗

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Updates to CoreValve Extreme Risk Study Encouraging

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content